Get started
Author

Jillian Roberts

Observed names: J. Roberts, Roberts, J.
ORCID: 0000-0002-2429-2541
Observed ORCID: 0000-0002-2429-2541
OpenAlex ID: A5033935058
Treatment of opioid dependence with depot buprenorphine (CAM2038) in custodial settings
2021 · Adrian J. Dunlop, Bethany White, et al. · Addiction · 55
Rapid upscale of depot buprenorphine (CAM2038) in custodial settings during the early COVID‐19 pandemic in New South Wales, Australia
2020 · Jillian Roberts, Bethany White, et al. · Addiction · 22
Health and correctional staff acceptability of depot buprenorphine in NSW prisons
2023 · Sophia Little, Bethany White, et al. · International Journal of Drug Policy · 20
Depot buprenorphine as an opioid agonist therapy in New South Wales correctional centres: a costing model
2022 · R. Ling, B. White, et al. · BMC Health Services Research · 18
PDF
Feasibility and acceptability of take‐home naloxone for people released from prison in New South Wales, Australia
2020 · Banafsheh Moradmand‐Badie, Lucy Tran, et al. · Drug and Alcohol Review · 11
Treatment satisfaction and patient reported outcomes among people with opioid use disorder participating in an open‐label, non‐randomised trial of long‐acting injectable buprenorphine treatment in Australian custodial settings
2025 · Bethany White, Sophia Little, et al. · Drug and Alcohol Review · 6
PDF
Substance use among pregnant women in NSW prisons
2023 · So Bi Kim, Bethany White, et al. · International Journal of Drug Policy · 6
“What's the point of telling them?”: Unspoken struggles of pregnant women with substance use history in Australian prisons
2025 · So Bi Kim, Maja Lindegaard Moensted, et al. · Journal of Substance Use and Addiction Treatment · 3
PDF
Treatment of Opioid Dependence with Depot Buprenorphine (CAM2038) in Custodial Settings Is Safe, Effective and Cost-Effective
2020 · Adrian J. Dunlop, B. White, et al. · SSRN Electronic Journal · 2
Long‐Acting Injectable Buprenorphine in Prison: Insights From a Short‐Answer Survey of People in the Criminal Justice System Commencing Long‐Acting Injectable Buprenorphine During a Non‐Randomised Clinical Trial
2026 · Amelia Woods, Catherine Foley, et al. · Drug and Alcohol Review
Experiences of People Who Discontinue Long‐Acting Injectable Buprenorphine Treatment Recently Released From Prison in New South Wales, Australia
2026 · Lucy J. D. Peck, Bethany White, et al. · Drug and Alcohol Review
PDF
Alcohol relapse prevention health care after alcohol withdrawal in New South Wales prisons, Australia: A patient file review
2023 · Yichao Liang, Jillian Roberts, et al. · Drug and Alcohol Review
PDF
Additional file 1 of Depot buprenorphine as an opioid agonist therapy in New South Wales correctional centres: a costing model
2022 · Ling, R., White, B., et al. · Figshare
Works count: 15
Citation count: 143
H-index: 6
I10-index: 5
Year
Topic
Type